Elsevier

Psychiatry Research

Volume 118, Issue 3, 15 June 2003, Pages 197-207
Psychiatry Research

A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia

https://doi.org/10.1016/S0165-1781(03)00094-5Get rights and content

Abstract

Previous research suggests that patients with schizophrenia demonstrate deficits in a range of parameters of motor cortical and cognitive inhibition. I-wave facilitation and long-interval cortical inhibition (LICI) are two paired pulse transcranial magnetic stimulation paradigms that appear to assess aspects of cortical inhibitory function that have not previously been assessed in this patient group. Eighteen patients with schizophrenia (nine medication-free) were compared with eight control subjects. We assessed resting motor threshold (RMT) levels, LICI and I-wave facilitation. RMT levels did not differ between the three groups. There was a significant overall difference in I-wave facilitation levels. Both patient groups as compared with the control group showed increased facilitation. There were no differences between the groups in the measure of LICI. Patients with schizophrenia appear to have increased I-wave facilitation. Increased I-wave facilitation suggests deficient function of cortical inhibitory GABAergic activity. This is consistent with previous research that has found deficient cortical inhibition in patients with schizophrenia.

Introduction

A number of studies have suggested that schizophrenia may involve an abnormality of the functioning of cortical inhibitory circuits. Studies of this sort initially utilized a variety of cognitive and evoked potential paradigms to demonstrate deficits in aspects of inhibitory processing. In an example of this type of research, Freedman et al., in a series of studies, demonstrated that patients with schizophrenia demonstrated reduced inhibition of the P50 auditory evoked potential in a paired pulse conditioning–test stimulus paradigm (Freedman et al., 1996, Freedman et al., 1983, Freedman et al., 1997). Differences between patients and controls have also been found in a series of cognitive priming paradigms designed to assess the capacity of subjects to inhibit aspects of automatic or planned responses, although this literature is complex and its findings not completely clear (e.g. Park et al., 2002, Peters et al., 2000, Williams, 1996).

More recently, a number of transcranial magnetic stimulation (TMS) techniques have been used to explore inhibitory processes in the motor cortex in schizophrenia. The motor cortex is of interest in the disorder as there is clear evidence of abnormalities in motor function that are independent of the effects of antipsychotic medication and may precede the onset of the disorder. For example, Walker et al. described choreoathetoid movements and posturing of the upper limbs in children who would later develop schizophrenia (Walker et al., 1994), and abnormalities in motor control have been described in neuroleptic-naive first onset patients (Caligiuri and Lohr, 1994). TMS paradigms used to date to assess inhibitory processes include the cortical silent period (CSP), cortical inhibition (CI) produced with paired pulse TMS (ppTMS) and inter-hemispheric inhibition (IHI) (also known as transcallosal inhibition) (Appendix A). The CSP is a period of suppression of tonic motor activity that follows descending excitatory activity produced by a TMS stimulus to the motor cortex (Cantello et al., 1992). It appears to be predominately the result of cortical activity, especially at GABAB receptors (Sanger et al., 2001, Werhahn et al., 1999). Studies of the CSP have found a reduction in its duration in both unmedicated (Daskalakis et al., 2002) and medicated patients compared to controls (Fitzgerald et al., 2002b). The degree of CI produced with ppTMS models using a short inter-stimulus interval (SICI) also appears to be a cortical effect, but it is determined by activity at GABAA receptors (Kujirai et al., 1993, Sanger et al., 2001). The degree of SICI has been the focus of several studies. The first of these reported a reduction compared to controls in patients receiving treatment with atypical antipsychotic medication (Fitzgerald et al., 2002b). Subsequently a reduction in SICI has also been reported in unmedicated patients (predominately medication naive) (Daskalakis et al., 2002), although reduced SICI was only reported in medicated, but not unmedicated patients, in a second study (Pascual-Leone et al., 2002). IHI has also been explored in several studies. Three groups have reported abnormal IHI with a method utilizing unilateral stimulation of the motor cortex (Boroojerdi et al., 1999, Fitzgerald et al., 2002a, Hoppner et al., 2001), and two studies using bilateral cortical stimulation techniques have also demonstrated changes (Daskalakis et al., 2002, Fitzgerald et al., 2002a).

Several other paradigms have been developed that are useful in the assessment of inhibitory function in the brain. The first involves a ppTMS paradigm but with differing stimulus properties than those previously described. In this paradigm, long-interval cortical inhibition (LICI) (Kujirai et al., 1993) is assessed with an initial supra-threshold stimulus combined with a supra-threshold second stimulus. The initial stimulus will produce an inhibition of the evoked motor response to the second (test) stimulus when presented at an appropriate inter-stimulus interval (50–200 ms) (Nakamura et al., 1997, Valls-Sole et al., 1992). LICI also appears to be a cortical event related to GABAB activity (Nakamura et al., 1997, Sanger et al., 2001).

The second paradigm involves assessment of descending I-wave facilitation. TMS of the human motor cortex results in multiple discharges in the cortico-spinal tract (Ziemann et al., 1998a). The first descending volley is produced by direct neuronal stimulation (D-wave), and this is followed by waves of activation produced through the stimulation of cortical interneurones (I-waves) (Ziemann and Rothwell, 2000). With a paired pulse protocol that differs from that described above, the facilitation of I-wave activity is assessed. This protocol involves paring a supra-threshold first and sub-threshold second stimulus (Ziemann et al., 1998a). It has been shown that the production of I-waves is dependent on GABA function; in particular, enhanced GABAergic activity at GABAA receptors suppresses the facilitatory I-wave activity (Ziemann et al., 1998b).

The aim of this study was to extend previous research into inhibitory deficits in schizophrenia by assessing LICI and I-wave facilitation in patients with the disorder. We tested both paradigms in a group of medication-free patients, a group of patients currently receiving antipsychotic medication and a group of normal control subjects. We hypothesized that the patient groups would demonstrate reduced LICI and increased I-wave facilitation.

Section snippets

Subjects

The study included 18 out-patients with a diagnosis of schizophrenia (DSM IV-SCID) and eight controls recruited through newspaper advertisement. All normal volunteers were screened for psychopathology by a trained clinician. Subjects were excluded if they had co-morbid psychiatric, neurological or medical illness, concurrent substance or alcohol abuse or concurrent treatment with anticonvulsant medication or lithium. Subjects were also excluded who were taking long-acting benzodiazepines.

Results

All subjects completed the procedures without difficulty, and there were no adverse events or side effects produced. Mean scores for the dependent variables and for RMT levels are presented in Table 2. There was no difference in RMT levels between the three groups. Psychopathology levels were not significantly different between the groups, and there was minimal parkinsonism reported in both groups (Table 1).

Discussion

The results of the study indicate that patients with schizophrenia demonstrate an abnormality of I-wave facilitation but a normal level of LICI compared to a normal control group. Although not completely clear, the abnormality in I-wave facilitation does not appear to be purely related to antipsychotic medication. These data do suggest that antipsychotic medication does not rectify these inhibitory deficits.

The most important and novel finding of the study is in the abnormality of I-wave

Acknowledgements

The study was supported by a National Health and Medical Research Council grant (143651) and a grant from The Stanley Medical Research Institute. We would like to thank all the patients and control subjects that participated in the study.

References (47)

  • P. Tigges et al.

    Digitized analysis of abnormal hand-motor performance in schizophrenic patients

    Schizophrenia Research

    (2000)
  • H. Tokimura et al.

    Short latency facilitation between pairs of threshold magnetic stimuli applied to human motor cortex

    Electroencephalography and Clinical Neurophysiology

    (1996)
  • J. Valls-Sole et al.

    Human motor evoked responses to paired transcranial magnetic stimuli

    Electroencephalography and Clinical Neurophysiology

    (1992)
  • S. Wischer et al.

    Piracetam affects facilitatory I-wave interaction in the human motor cortex

    Clinical Neurophysiology

    (2001)
  • U. Ziemann et al.

    Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs

    Electroencephalography and Clinical Neurophysiology

    (1997)
  • U. Ziemann et al.

    Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study

    Electroencephalography and Clinical Neurophysiology

    (1998)
  • S. Akbarian et al.

    GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls

    Cerebral Cortex

    (1995)
  • B. Boroojerdi et al.

    Transcallosal inhibition and motor conduction studies in patients with schizophrenia using transcranial magnetic stimulation

    British Journal of Psychiatry

    (1999)
  • R. Cantello et al.

    Magnetic brain stimulation: the silent period after the motor evoked potential

    Neurology

    (1992)
  • R. Chen

    Studies of human motor physiology with transcranial magnetic stimulation

    Muscle and Nerve

    (2000)
  • Z.J. Daskalakis et al.

    Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation

    Archives of General Psychiatry

    (2002)
  • S.A. Edgley et al.

    Comparison of activation of corticospinal neurons and spinal motor neurons by magnetic and electrical transcranial stimulation in the lumbosacral cord of the anaesthetized monkey

    Brain

    (1997)
  • P.B. Fitzgerald et al.

    The application of transcranial magnetic stimulation in psychiatry and neurosciences research

    Acta Psychiatrica Scandinavica

    (2002)
  • Cited by (44)

    • Investigating the neurobiology of schizophrenia and other major psychiatric disorders with Transcranial Magnetic Stimulation

      2018, Schizophrenia Research
      Citation Excerpt :

      Similarly, MEP amplitude did not differ between SCZ and HC across eight studies (Table 1). Furthermore, no differences were found in ICF in individuals at risk of schizophrenia (Hasan et al., 2012), first-episode (Eichhammer et al., 2004; Wobrock et al., 2009; Wobrock et al., 2008), and both medicated and unmedicated chronic SCZ (Daskalakis et al., 2002; Daskalakis et al., 2008a; Fitzgerald et al., 2002a, 2002b; Hasan et al., 2011; Liu et al., 2009; Pascual-Leone et al., 2002) relative to HC, whereas I-wave facilitation was increased in both medicated (N = 9) and unmedicated (N = 9) SCZ compared with HC (N = 9), although data are from a single study on a small group of patients (Fitzgerald et al., 2003). In a meta-analysis of excitability measures in patients with MDD and healthy controls, no group differences were found in rMT (MDD: N = 176; healthy controls: N = 188) or ICF (MDD: N = 115; healthy controls: N = 130) (Radhu et al., 2013).

    • Determining optimal rTMS parameters through changes in cortical inhibition

      2014, Clinical Neurophysiology
      Citation Excerpt :

      That is, while accumulation of inhibition occurs, there appears to be a minimum number of stimuli needed to achieve such a response. Future studies, particularly treatment studies, should aim to individualize or personalize this pulse threshold and follow its course over daily sessions to evaluate whether repeated daily sessions potentiate such inhibitory processes further, particularly in psychopathology, where inhibitory deficits appear to be ubiquitous (Daskalakis et al., 2002a; Farzan et al., 2010a; Fitzgerald et al., 2003b; Greenberg et al., 2000; Levinson et al., 2010; Richter et al., 2011). Neurophysiologic studies investigating the effects of rTMS on cortical inhibition can be used to guide treatment.

    • GABAergic activity in autism spectrum disorders: An investigation of cortical inhibition via transcranial magnetic stimulation

      2013, Neuropharmacology
      Citation Excerpt :

      It should be noted, however, that CSP has been suggested to reflect either GABAA or GABAB receptor activity depending on the stimulus intensity used (Kimiskidis et al., 2006), and some studies have failed to show modulation of CSP via a GABAB receptor agonist (Inghilleri et al., 1996; McDonnell et al., 2006; Ziemann et al., 1996). These TMS paradigms have been used with success in elucidating the neuropathophysiology of psychiatric conditions such as depression (Levinson et al., 2010) and schizophrenia (Farzan et al., 2010; Fitzgerald et al., 2003), but to our knowledge have only been employed twice in ASD. Our preliminary study of cortical inhibition in ASD revealed evidence for reduced GABAergic activity in those diagnosed with DSM-IV autistic disorder, but this impairment did not extend to those diagnosed with DSM-IV Asperger's disorder (Enticott et al., 2010).

    View all citing articles on Scopus
    View full text